Literature DB >> 13925168

Antigenic value of lyophilized phenolized antirabies vaccine.

N VEERARAGHAVAN, T P SUBRAHMANYAN.   

Abstract

The authors present the results of experiments, carried out at the Pasteur Institute of Southern India, Coonoor, in which various preparations of lyophilized and liquid phenolized antirabies vaccines were assessed for antigenicity in relation to the NIH (United States National Institutes of Health) Reference Vaccine 164 (the proposed International Reference Preparation of Rabies Vaccine). The claim that phenolized antirabies vaccines can be lyophilized without loss of antigenicity was fully substantiated: the lyophilized vaccines were found to possess high antigenic values and to retain their antigenicity better than the liquid vaccines during storage under the same conditions.

Keywords:  RABIES/immunology; VACCINES

Mesh:

Substances:

Year:  1961        PMID: 13925168      PMCID: PMC2555537     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  Improvement of the antigenicity of antirabies vaccine by pooling checked by post-challenge vaccination of guinea-pigs.

Authors:  N VEERARAGHAVAN
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

  1 in total
  1 in total

1.  An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.

Authors:  Reed F Johnson; Drishya Kurup; Katie R Hagen; Christine Fisher; Rohan Keshwara; Amy Papaneri; Donna L Perry; Kurt Cooper; Peter B Jahrling; Jonathan T Wang; Jan Ter Meulen; Christoph Wirblich; Matthias J Schnell
Journal:  J Infect Dis       Date:  2016-07-24       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.